A phase II trial of Lyme vaccine VLA-15 for Lyme disease.
Phase of Trial: Phase II
Latest Information Update: 25 Jul 2017
At a glance
- Drugs VLA 15 (Primary)
- Indications Lyme disease
- Focus Pharmacodynamics
- 25 Jul 2017 Planned initiation date changed to 1 Jan 2018.
- 24 Jul 2017 According to a Valneva media release, the company plans to initiate this study in the first quarter of 2018.
- 29 Mar 2017 New trial record